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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYThe in vitro derivation of hematopoietic stem cells (HSCs) from pluripotent stem cells (PSCs) is complicated by the existence of multiple
overlapping embryonic blood cell programs called primitive, erythromyeloid progenitor (EMP), and definitive. As HSCs are only gener-
ated during the definitive stage of hematopoiesis, deciphering the regulatory pathways that control the emergence of this program and
identifyingmarkers that distinguish it from the other programs are essential. To identify definitive specific pathways andmarker sets, we
used label-free proteomics to determine the proteomeof embryo-derived andmouse embryonic stem cell-derivedVE-CADHERIN+CD45
definitive hematopoietic progenitors. With this approach, we identified Stat1 as a marker that distinguishes the definitive erythroid line-
age from the primitive- and EMP-derived lineages. Additionally, we provide evidence that the generation of the Stat1+ definitive lineage is
dependent on Sox17. These findings establish an approach for monitoring the emergence of definitive hematopoiesis in the PSC differ-
entiation cultures.INTRODUCTION
The generation of hematopoietic stem cells (HSCs) from
pluripotent stem cells (PSCs) is dependent on our ability
to accurately recapitulate the intricate steps of early embry-
onic hematopoietic development in the differentiation cul-
ture. The mammalian embryonic hematopoietic system
consists of at least three distinct programs—primitive,
erythromyeloid progenitor (EMP)/yolk sac definitive, and
intraembryonic definitive—that differ in their potential
as well as spatial and temporal patterns of development
(McGrath et al., 2011; Medvinsky and Dzierzak, 1996; Palis
et al., 1999). Primitive hematopoiesis is the first to develop,
initiates in the yolk sac at embryonic day 7.0 (E7.0), and
produces a restricted repertoire of hematopoietic cells con-
sisting of primitive erythrocytes that express embryonic
forms of globin and macrophages. Shortly after the onset
of primitive hematopoiesis, the yolk sac generates a cohort
of erythroid, myeloid, and megakaryocytic progenitors
that constitute a distinct phase of embryonic hematopoie-
sis known as the erythromyeloid progenitor program, also
referred to as the yolk sac definitive program (McGrath
et al., 2011). This program appears to be positioned devel-
opmentally between primitive and definitive hematopoie-
sis. In the mouse, it generates erythroid cells that express
adult and embryonic globins but does not give rise
to lymphoid lineage cells or hematopoietic stem cells
(McGrath et al., 2011; Palis et al., 1999). HSCs are generated
during the intraembryonic-definitive stage of hematopoie-Stem Csis that is specified following the emergence of the two
yolk sac programs at different sites within the embryonic
arterial vasculature, the most well characterized being
the developing aorta, gonad, and mesonephros (AGM)
(Medvinsky and Dzierzak, 1996). In addition to HSC and
lymphoid potential, murine definitive hematopoiesis is
distinguished from the two earlier programs by the fact
that the erythroid lineage expresses exclusively adult forms
of globin. Although both the EMP and intraembryonic-
definitive hematopoietic programs are considered to be
‘‘definitive’’ due to their ability to generate erythroid pre-
cursors, to distinguish between them in this study, we use
the terms EMP for the yolk-sac-derived progenitors and
definitive for those derived from intraembryonic sites.
There is now compelling evidence indicating that both
the EMP and definitive programs derive from progenitors
known as hemogenic endothelial cells (HECs) that display
endothelial markers and are associated with the arterial
vasculature (Bertrand et al., 2005; Boisset et al., 2010;
Clarke et al., 2013; Kissa and Herbomel, 2010). Live imag-
ing and histological analyses have demonstrated that he-
matopoietic progenitors develop from the HECs through
a process known as the endothelial to hematopoietic
transition (EHT) (Boisset et al., 2010; Kissa and Herbomel,
2010). Currently, there are no markers to distinguish
EMP-HECs from definitive HECs. As the EMP program de-
velops earlier than the definitive program, the EMP-derived
lineages can predominate the PSC differentiation cultures
and are often misinterpreted as representing definitiveell Reports j Vol. 5 j 291–304 j August 11, 2015 j ª2015 The Authors 291
hematopoiesis. Developing strategies to distinguish defini-
tive- from EMP-derived hematopoiesis in the PSC differen-
tiation cultures is essential for identifying the signaling
pathways that regulate the development of definitive
HECs and their specification to HSCs.
We have previously shown that SOX17 is expressed in
definitive HECs and that it is required for the establishment
of the definitive, but not the primitive, hematopoietic pro-
gram (Clarke et al., 2013). Our analysis of differentiated
hematopoietic progeny from HECs generated from
SOX17-null mouse embryonic stem cells (mESCs) revealed
the presence of primitive erythroid progenitors, myeloid
progenitors, and erythroid progenitors that gave rise to
large colonies distinct from the primitive erythroid col-
onies. The presence of this population of erythroid progen-
itors suggests that the EMP program may also be Sox17
independent. Our goals in the present study were to define
the role of Sox17 in EMP hematopoiesis, understand how
Sox17 regulates the generation of definitive hemogenic
endothelium, and identify additional markers to distin-
guish theseprograms. Toachieve thesegoals,wedeciphered
the proteome of AGM-derivedHECs and ofHECs generated
from Sox17-wild-type and Sox17-knockout mESCs using
label-free quantitative proteomics. The findings from these
studies demonstrate the overall utility of analyzing the pro-
teomeof small numbers of cells and showthat expressionof
the transcription factor Stat1 and dependency on Sox17
distinguish the definitive erythroid lineage from the primi-
tive and EMP-derived erythroid lineages.RESULTS
Proteomic Analyses of Wild-Type mESC- and
Embryo-Derived HEC-Containing Populations
To identify markers that distinguish the different HEC
populations and regulators that control their development,
we quantitatively measured the global protein expression
profile of mESC- and embryo-derived progenitors using
label-free proteomics. In the first set of experiments, we
isolated and analyzed the VE-CADHERIN+ (VEC) CD45
population from the AGM region of E10.5 and E11.5
mouse embryos. This population contains non-hemogenic
endothelial cells (ECs), HECs, and type I pre-HSCs at E10.5
and E11.5 (Rybtsov et al., 2011). The corresponding
VECCD45 fractions from the same embryos were
analyzed as representing the non-EC/HEC populations.
For the second set of samples, we focused onmESC-derived
populations. We previously described a chemically defined
serum-free and feeder-free differentiation protocol for
mESCs in which the primitive hematopoietic program is
identified as an early arising FLK-1+ population (day 3.25
[D3.25]) and the definitive program as a FLK-1+ population292 Stem Cell Reports j Vol. 5 j 291–304 j August 11, 2015 j ª2015 The Autthat emerges at D5.25 (Clarke et al., 2013; Irion et al.,
2010). When isolated and cultured for an additional
2 days (total day 7 [D7]) these definitive D5.25 FLK-1+ cells
give rise to an endothelial VEC+ population that contains
HECs that undergo the EHT to generate CD45+ hematopoi-
etic cells at D9. The D5.25 FLK-1+ progenitors and deriva-
tive D7 VEC+CD45 cells were isolated from two separate
mESC lines (mESC-1 and mESC-2) and subjected to prote-
omic analyses (Figure 1A).
For all analyses, protein digests were measured by
nano-liquid chromatography-tandem mass spectrometry
(nano-LC-MS/MS) on a Q Exactive mass spectrometer and
quantified using label-free methods (Luber et al., 2010).
In total, 36,678 peptides corresponding to 4,044 proteins
were quantified in both the in vivo and in vitro studies
(Table S1). Protein quantification was reproducible across
in vitro and in vivo measurements, with a Pearson’s corre-
lation between replicates of 0.89 and 0.90, respectively
(Figures 1B and 1C).
To validate that the proteomics analysis could accurately
distinguish between the EC/HEC and non-EC/HEC frac-
tions, we analyzed the E11.5 VEC+ and VEC populations
for proteins known to be expressed in HECs, including
ALDH1A2 (RALDH2), SCL/TAL1, CBFb, and ESAM. All
were enriched in the VEC+ fraction, confirming the utility
of this proteomic approach to accurately identify the HECs
within this heterogeneous cell population (Chanda et al.,
2013; Van Handel et al., 2012; Yokota et al., 2009) (Fig-
ure S1A; Tables S2 and S3). Next, we asked if our proteomics
analysis could identify differences between the E10.5
VEC+CD45 and E11.5 VEC+CD45 populations. The
E11.5 VEC+CD45 population contains more potent or
higher numbers of pre-HSCs than the E10.5 population
(Rybtsov et al., 2011; Yokomizo et al., 2012). We identified
85 proteins that were differentially expressed between
these populations (Figures S1B and S1C; Table S4). Among
the proteins expressed at higher levels in the E11.5 popula-
tion than in the E10.5 population, we identified STAM2
and SLFN1. STAM2 is a critical adaptor protein downstream
of growth factor and inflammatory cytokine signaling
pathways (Pandey et al., 2000). The identification of
STAM2 in the E11.5 population is of interest, as recent
studies indicate that inflammatory signaling plays a crucial
role in the emergence of HSCs (Espı´n-Palazo´n et al., 2014;
Li et al., 2014; Sawamiphak et al., 2014). SLFN1 is amember
of the Schlafen family of proteins that are expressed in
endothelial and hematopoietic cells and are emerging as
important regulators of the immune response (Kuang
et al., 2014; Schwarz et al., 1998). By contrast, ESAM (endo-
thelial cell selective adhesion molecule), which is a marker
of emerging multipotent stem and progenitor cells, and
members of the RAS signaling pathway (RAB17 and
SIPA1) were found at higher levels in the E10.5 population.hors
Figure 1. Quantitative Proteomic Profiling of Hemogenic Endothelium
(A) Proteomic workflow used to identify differentially regulated protein expression in vitro and in vivo.
(B) Label-free quantification of protein expression in vitro is reproducible. Tryptic digestions of cell lysates were analyzed by nano-LC MS/
MS. n = 3 individual measurements; Pearson correlation of 0.89.
(C) Label-free quantification of protein expression in vivo is reproducible. Tryptic digestions of mouse tissue were analyzed as in (B). n = 3
individual measurements; Pearson correlation of 0.90.
(D) Protein expression was analyzed by unsupervised hierarchal cluster analysis (HC). Green denotes high, relative protein expression and
blue low, relative protein expression.
(E) Protein expression was analyzed by principle-component analysis.
(F) GO terms linked to proteins enriched in VE-CADHERIN+ populations were analyzed in G-profiler using the cocoa algorithm.
See also Figure S1
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Lastly we compared our D7 mESC-derived ECs/HECs
to the E10.5 and E11.5 VEC+CD45 ECs/HECs (Figure 1D).
Principle-component analysis revealed that the VEC+
populations from the two mESC lines were similar to one
another. Component 2 reflects the variance between
E10.5 AGM and E11.5 AGM. Based on this analysis, the
mESC-derived populations appear to represent a stage of
development between them. Component 1 is an indica-
tion of the variance between in vivo and in vitro culture
conditions. As expected, cells grown in vitro do not
perfectly recapitulate in vivo development (Figure 1E).
Gene Ontology (GO) analysis showed that proteins linked
to anchoring junctions, including calcium ion binding
and calcium-dependent phospholipid binding, were
more highly expressed in the AGM VEC+CD45 and
VECCD45 cells than the D7 mESC-derived cells (Fig-
ure 1F). Collectively, these findings highlight the power
of the label-free proteomics approach for assessing protein
expression in a small number of cells, and in doing so,
they identify candidate signaling pathways that may play
a role in the generation of HSCs from HECs in vitro.
Determination of the SOX17-Dependent Proteome in
mESC-Derived HEC-Containing Populations
We previously reported that SOX17 is a critical regulator of
hemogenic endothelium development in vivo and during
the directed differentiation of mESCs in vitro (Clarke
et al., 2013). However, the direct targets of SOX17 required
for the generation of HECs are unknown. In our previous
studies, we demonstrated that the doxycycline-inducible
overexpression of SOX17 in FLK-1+ mESC-derived endo-
thelial progenitors increased the formation of HECs while
repressing the endothelial to hematopoietic transition.
We therefore hypothesized that the quantitative measure-
ment of changes in protein expression following the
induced expression of SOX17 would identify both direct
and indirect target proteins of SOX17 during the genera-
tion of HECs. D5.25 FLK-1+ endothelial progenitors were
isolated and treated with doxycycline for 1–3 days to
induce the expression of SOX17. Samples were isolated
fromD6 toD9 and analyzed for total protein expression us-
ing label-free proteomics (Figure S2A). In total, SOX17
directly or indirectly regulated the expression of 110 pro-
teins (Figure S2B; Table S5) that we classified into early,
mid, or late effectors (Figure S2D). SOX17 has been impli-
cated as both a transcriptional activator and repressor, sug-
gesting that proteins that exhibit a significant increase or
decrease immediately following the induction of SOX17
may be direct transcriptional targets of SOX17 in HECs.
We not only quantified changes in SOX17 expression (Fig-
ures S2B and S2C) but also identified several proteins that
have been suggested to be targets of SOX17 in other cell
systems, including UCHL1 (extraembryonic endoderm294 Stem Cell Reports j Vol. 5 j 291–304 j August 11, 2015 j ª2015 The Autdevelopment) (Sinner et al., 2004) and CDKN1C (p57/
KIP2, respiratory epithelial cells) (Lange et al., 2009) (Table
S5). Consistent with our previous observation that the
enforced expression SOX17 promotes the maintenance
and expansion of HECs, thus postponing the EHT (Clarke
et al., 2013), we identified that SOX17 overexpression
decreased the expression of proteins linked to the erythro-
cyte function during the time course of directed differenti-
ation (Figures S2E and S2F). Taken together, we expect that
this proteomic dataset will be a useful resource for re-
searchers seeking to identify regulators of the expansion
and maintenance of HECs.
As SOX17 is required for the establishment of definitive,
but not primitive, hematopoiesis, we hypothesized that
analysis of the SOX17-dependent proteome would reveal
previously unidentified insights into the global pathways
involved in the regulation and identification of these dispa-
rate hematopoietic programs. To investigate this, we next
analyzed the proteome of D7 VEC+CD45 cells generated
from control and Sox17/ mESCs (Figure 2A). We found
that 344 proteins were differentially expressed between
these populations (Figure 2B; Table S6). Among the differ-
ences, we noted that the SOX17-null VEC+ cells expressed
higher levels of erythrocyte-linked proteins (Figure 2C),
specifically those associated with the primitive and EMP
hematopoietic programs including the embryonic forms
of b-globin, HBB-εg and HBB-bH1 (Table S6). This is consis-
tent with our previous observation that the D7 Sox17/
VEC+ population is heterogeneous and contains
committed erythroid and myeloid progenitors as well as
HECs (Clarke et al., 2013). Interestingly, GO analysis iden-
tified that Stat transcription factors had decreased expres-
sion in the Sox17/ population compared to the control
cells (STAT1, STAT3, and STAT5B) (Figure 2C; Table S6).
Notably, STAT1 expression was significantly reduced in
the D7 Sox17/VEC+ cells, suggesting that it may be a pre-
viously unidentified transcriptional target of SOX17.
Consistent with the reduction in STAT1, we also observed
a significant reduction in its direct transcriptional target
ISG15 (Malakhov et al., 2003) (Figures 2D and S3A).
To determine whether SOX17 can directly activate Stat1
transcription, HEK293T cells were transfected with a
Sox17 expression plasmid along with a construct contain-
ing a 2.5-kb region of the Stat1 promoter that includes
four potential SOX17-binding sites upstream of luciferase
(JASPER database; data not shown). Transfection of Sox17
did not lead to induction of luciferase activity (Figure S3B).
Consistent with this observation, we did not detect bind-
ing of SOX17 to the Stat1 promoter by chromatin immuno-
precipitation (ChIP) analysis (data not shown). Finally, we
were unable to demonstrate an upregulation of Stat1
following the enforced expression of SOX17 in the D5.25
FLK-1+ cells using a doxycycline-inducible mESC linehors
Figure 2. Sox17-Regulated Protein
Expression
(A) Schematic outlining Sox17 proteomic
comparison.
(B) Protein expression was analyzed by
unsupervised hierarchal cluster analysis
(HC). Green denotes high, relative protein
expression and blue low, relative protein
expression.
(C) GO terms linked to proteins regulated by
Sox17 knockout were analyzed in G-profiler
using the cocoa algorithm.
(D) STAT1 and ISG15 protein expression
was quantified by nano-LC-MS/MS on a Q
Exactive. n = 3 individual measurements.
*p < 0.01.
See also Figure S2.(Figure S3C). Collectively, these findings provide strong
evidence that Stat1 is not a direct target of SOX17 in the
VEC+ cells and in doing so support an alternative interpre-
tation in which Stat1 is expressed in a definitive hemato-
poietic progenitor that is regulated by SOX17.
Expression of Stat1 in Embryo-Derived Erythroid
Populations
The observed differences in globin gene expression be-
tween the wild-type and SOX17-null VEC+CD45 popula-
tions indicate that they are heterogeneous and additional
markers are needed to identify the type of hematopoietic
progenitors present within them. As previous studies
have shown that CD41 is expressed on emerging primi-
tive and definitive hematopoietic progenitors, including
those of the erythroid lineage (Ferkowicz et al., 2003;
Mitjavila-Garcia et al., 2002), we next analyzed D7 wild-
type and Sox17/ VEC+CD45 populations for the pres-
ence of this marker. Approximately half the wild-type
VEC+CD45 population expressed CD41, whereas more
than 80% of the SOX17-null cells were positive (Fig-Stem Cure S3D). These findings show that the VEC+CD45 popu-
lations used for the proteomic analyses contained CD41+
hematopoietic progenitors and raise the interesting possi-
bility that the differences in Stat1 and globin expression
between the two reflect differences in their erythroid pro-
genitor content. Specifically, they support the hypothesis
that Stat1 is expressed in an erythroid progenitor that is
regulated by SOX17. Differential expression of the Stat
regulators in different erythroid populations is in line
with a recent computational study that provided evidence
that STAT3 signaling is required for primitive erythropoi-
esis, whereas Stat1 is preferentially expressed during
the definitive stage (Greenfest-Allen et al., 2013). EMP-
derived erythroid progenitors were not examined in these
experiments.
To determine if expression of Stat1 distinguishes the
erythroid lineages generated from the different embryonic
hematopoietic programs, we monitored its expression as
well as that of other Stat genes in the primitive, EMP-
derived, and definitive erythroid cells (Figure 3A) obtained
from wild-type and SOX17-null embryos and mESCsell Reports j Vol. 5 j 291–304 j August 11, 2015 j ª2015 The Authors 295
Figure 3. Primitive, EMP, and Definitive
Erythroid Cells Have Distinct Gene
Expression Signatures In Vivo
(A) Previously published expression pat-
terns of globin genes and transcriptional
regulators in mouse erythroid cells
(B) Erythroid potential of E8.5 yolk sac (YS)
and E14.5 fetal livers. Bars represent SEM
number of colonies per yolk sac from 7 E8.5
embryos and per 1 3 105 cells from the
livers of 5 E14.5 embryos. The tissues were
obtained from two dams.
(C) Real-time qPCR analysis of the indicated
genes in Ery-P, Ery-EMP, and Ery-D colonies
from E8.5 YS and E14.5 fetal livers. Values
represent SEM; n = 5 individual experi-
ments. ***p < 0.005, **p < 0.01, *p < 0.05.
Ery-P colonies were picked following 5 days
of culture, and Ery-EMP and Ery-D colonies
were picked following 8 days of culture.
Colonies were pooled for RNA extraction.
See also Figure S3.differentiated in culture. In the mouse, the primitive
erythroid (Ery-P), EMP-derived (Ery-EMP), and definitive
erythroid (Ery-D) cells can be distinguished based on
distinct b-globin gene expression patterns. Ery-P cells ex-
press high levels of the embryonic b-globin HBB-bH1 and
HBB-εg and low levels of the adult forms b-globin Hbb-
b1/b2. Ery-EMP cells express low levels of HBB-bH1 and
HBB-εg, and an increased amount of HBB-b1/b2 (McGrath
et al., 2011). Ery-D cells express exclusively the adult b-glo-
bins HBB-b1/b2. In addition to patterns of globin expres-
sion, the development of these erythroid populations can
be monitored by the expression of specific transcription
factors. EKLF/KLF1 regulates the expression of several
erythroid-specific genes, including both embryonic and
adult globin, and is present in all three erythroid popula-
tions (Basu et al., 2007; Hodge et al., 2006). Sox6 and
Bcl11A are expressed in the EMP and definitive erythroid
cells, where they function to suppress the embryonic296 Stem Cell Reports j Vol. 5 j 291–304 j August 11, 2015 j ª2015 The Autglobin genes (Sankaran et al., 2009; Yi et al., 2006). Neither
is expressed in the primitive erythroid lineage.
E8.5 yolk sacs (YS) and E14.5 fetal livers (FL) were isolated
and the cells from each cultured in methylcellulose for
the generation of primitive, EMP (E8.5 YS), and definitive
(E14.5 FL) erythroid colonies, respectively (Figure 3B).
The subsets of colonies were identified based on pheno-
type, then picked, pooled, and analyzed by real-time
qPCR for gene expression profiles (Figure 3A). As expected,
primitive erythroid colonies expressed high levels of Hbb-
εg and low levels of Hbb-b1. Additionally, they expressed
Stat3, as previously reported (Greenfest-Allen et al., 2013).
The primitive erythroid colonies expressed only low levels
of the other Stat genes and Eklf. They had no detectable
levels of Sox6 or Bcl11a. In contrast, the fetal-liver-derived
definitive colonies expressed high levels of adult b-globin
(Hbb-b1) but no embryonic (Hbb-εg, Hbb-bh1) globin.
These colonies also expressed Stat1, Eklf, Sox6, andhors
Bcl11a (Figure 3C). Only low levels of Stat3, Stat5a, and
Stat5b were detected in the definitive cells. As a means to
categorize the real-time qPCR values, wewill consider a del-
taCT (DCT) level of >50 as ‘‘high’’ for globin genes and
>0.02 as high for transcription factors. The EMP-derived
erythroid colonies expressed a mixture of low levels of
embryonic and adult b-globin, as well as Eklf, Sox6, and
Bcl11a. Interestingly, these erythroid colonies showed
low expression levels of all STAT proteins. Together,
these data show that embryo-derived primitive, EMP, and
definitive erythroid cells have distinct gene expression
signatures and that the expression of Stat1 distinguishes
between EMP and definitive erythroid cells.
Expression of Stat1 in mESC-Derived Wild-Type and
Sox17/ Erythroid Populations
We next examined if this gene expression signature can be
used to distinguish the ESC-derived erythroid lineages
generated from both wild-type and Sox17/ ESCs. The
Sox17/ populations were included, as our previous study
indicated that development of primitive and EMP pro-
grams were SOX17 independent, whereas specification of
the definitive lineage required SOX17. In the initial set of
experiments, we analyzed the primitive and EMP lineages
generated from D3.25 FLK-1+ mesoderm, a population
that we have previously shown gives rise to the equivalent
of yolk sac hematopoiesis (Clarke et al., 2013; Irion et al.,
2010). For these studies, the wild-type (control) and
Sox17/ FLK-1+ cells were isolated by fluorescence-acti-
vated cell sorting (FACS) and aggregated overnight. The
aggregates were cultured for 48 hr (Figure 4A). As an inde-
pendent method to distinguish the different erythroid
progenitors, we analyzed their dependency on NOTCH
signaling, as previous studies have shown that the primi-
tive and EMP hematopoietic programs are NOTCH inde-
pendent whereas specification of the definitive program
is dependent on this pathway (Hadland et al., 2004). To
measure NOTCH dependency, we included the NOTCH
pathway antagonist gamma secretase inhibitor (gSI) in
the aggregate cultures. The resulting populations were as-
sayed in methylcellulose. Both the wild-type and Sox17/
D3.25 FLK-1+ populations generated typical small primi-
tive erythroid (Ery-P) colonies as well as larger erythroid
colonies that resembled those that develop from either
EMP or definitive progenitors (Ery-EMP/D) (Figure 4B).
Although the erythroid potential was intact in the
Sox17/mesoderm, the cellularity as well as the frequency
of Ery-P and Ery-EMP progenitors was significantly lower in
the Sox17/ cultures than in the wild-type cultures (Fig-
ure 4C). The reduced cellularity in Sox17/ populations
is consistent with observations in our previous study
(Clarke et al., 2013). The addition of gSI did not signifi-
cantly affect cell numbers or the generation of Ery-P pro-Stem Cgenitors from eithermESC line (Figure 4D). It did, however,
lead to amodest but significant reduction in the number of
larger wild-type colonies (Ery-EMP/D) indicating that a
subset of them originate from a NOTCH-dependent defin-
itive hematopoietic progenitor or that NOTCH is involved
in the proliferation, but not emergence, of EMP hemato-
poietic progenitors. (Figure 4D, black bars). The number
of Sox17/ Ery-EMP/D progenitors was not affected by
the addition of gSI (Figure 4D, gray bars).
The wild-type and Sox17/ Ery-P colonies had a gene
expression signature similar to that of the E8.5 YS-derived
primitive erythroid cells, including high levels of Hbb-εg
and Stat3 (Figure 4E). They also expressed low levels of
Eklf and the other Stat genes. Sox6 and Bcl11a were not ex-
pressed in these colonies. The expression profile of the
wild-type Ery-EMP colonies was also in line with that of
the YS-derived colonies and showed significantly lower
levels of embryonic globin Hbb-εg and Stat3 than the
Ery-P colonies. As observed with the yolk sac colonies,
the mESC-derived Ery-EMP colonies also had low levels of
all the other Stat genes tested. These colonies did express
Eklf, Sox6, and Bcl11a (Figure 4F, black bars). The
Sox17/-derived colonies had a similar ‘‘EMP’’ profile,
including low levels ofHbb-εg and the Stat genes. These col-
onies did, however, express lower levels of Hbb-b1 and
Eklf than thewild-type colonies. The reason for these differ-
ences is currently not clear.
To generate ESC-derived definitive progenitors, D5.25
FLK-1+ cells were isolated, aggregated, and cultured over-
night (Figure 5A). The aggregates were then plated as a
monolayer in the presence of cytokines known to induce
the EHT and the generation of CD45+ hematopoietic pro-
genitors. gSI was included in some of the cultures during
the aggregation and Matrigel stages. The wild-type and
Sox17/ D9 populations gave rise to erythroid colonies
that phenotypically resembled those derived from Ery-
EMP or Ery-D progenitors (Figure 5B). Primitive erythroid
colonies were not detected in these cultures. The addition
of gSI did not impact overall cellularity, but it did lead to
a reduction in the proportion of CD41+ cells and in the
number of erythroid colonies generated in the wild-type
population, consistent with the interpretation that they
represent the definitive lineage (Figures 5C–5E, black
bars). In contrast, neither the size of the Sox17/ CD41+
population nor the number of Sox17/ erythroid colonies
was affected by the addition of gSI, indicating that these
cells represent the EMP program. Gene expression analysis
confirmed these differences as the control erythroid col-
onies revealed an expression pattern comparable to the
FL-derived definitive lineage, including Hbb-b1hi, Hbb-
εgneg, Stat1hi, Eklf hi, Sox6+, and Bcl11a (Figure 5F, black
bars). The Sox17/ colonies, by contrast, displayed an
EMP profile that included significantly lower levels ofell Reports j Vol. 5 j 291–304 j August 11, 2015 j ª2015 The Authors 297
Figure 4. Day 3.25 FLK-1+ Wild-Type and Sox17/ mESC-Derived Populations Contain Primitive and EMP Progenitors
(A) Schematic representation of the differentiation protocol for generating different hematopoietic populations from mESCs.
(B) Representative image of erythroid colonies from a control D5 population generated from D3.25 FLK-1+ cells after 5 days in culture.
(C) Fold change in cell numbers following 48 hr of culture of control and Sox17/ D3.25 FLK-1+ cells in the presence and absence of
g-secretase inhibitor (gSI, L685458, Tocris, 10 mM). Cells cultured in the vehicle DMSO represent the control. DMSO p = 0.00958, gSI
p = 0.0285. n = 3 individual experiments (SEM).
(D) Erythroid potential of the D5 population generated from D3.25 FLK-1+ cells. n = 3 individual experiments (SEM). Control EryP
DMSO:Sox17/ DMSO p = 0.031, control EryP gSI:Sox17/ gSI p = 0.012, control Ery-EMP DMSO:control Ery-EMP gSI p = 0.024, control
Ery-EMP DMSO:Sox17/ Ery-EMP DMSO p = 0.0039, and control Ery-EMP gSI:Sox17/ Ery-EMP gSI p = 0.0032.
(legend continued on next page)
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Stat1 andHbb-b1 expression than observed in thewild-type
definitive colonies. Taken together, these findings show
that combination of Stat1 and globin gene expression
can be used to distinguish the different mESC-derived
erythroid programs. Additionally, they confirm our earlier
interpretation that the primitive and EMP programs are
not dependent on SOX17, whereas generation of the defin-
itive lineage is SOX17 dependent. Finally, they show that
the EMP-derived erythroid lineage persists to the definitive
stage in the Sox17/ cultures.SOX17 Is Not Required for Development of the
Primitive and EMP-Derived Erythroid Lineage In Vivo
To evaluate the SOX17 dependency of primitive and EMP
erythroid lineages in vivo, we next analyzed colonies
generated from the yolk sacs of E8.5 Sox17+/+, Sox17+/,
and Sox17/ embryos for the above expression signature.
As observed with the mESC-derived populations, the
SOX17-deficient (Sox17+/ and Sox17/) embryos con-
tained a lower frequency of primitive erythroid progenitors
than the wild-type littermates, possibly due to defects in
the yolk sac vasculature resulting from SOX17 deficiency
(Kim et al., 2007). In spite of the reduced numbers, the col-
onies from the three different sets of embryos had very
similar expression profiles that included high levels of
Hbb-εg and Stat3 and low levels of the other Stat genes (Fig-
ures 6A and 6B). Both the Sox17+/ and Sox17/ embryos
contained progenitors that generated EMP-type colonies.
The expression pattern of these colonies was consistent
with that of the EMP, with the exception that those derived
from the Sox17/ progenitors expressed lower levels Hbb-
b1 than the colonies from the Sox17+/ and Sox17+/+ pro-
genitors, similar to the pattern seen in the Sox17/
mESC-derived EMPs (Figure 5F). Collectively, these data
show that SOX17 is not required for the emergence of
primitive and EMP-derived hematopoietic program in the
embryo.DISCUSSION
Label-free proteomics represents an emerging technology
for identifying and quantifying patterns of protein expres-
sion. While differences in patterns of protein expression
have previously been shown to correlate with differenti-
ated cell types, it has been much more challenging to
develop technologies that can detect regulatory proteins(E and F) Real-time qPCR analysis of the erythroid colonies. n = 3 indiv
p = 0.00012. In addition, but not labeled in the figure, the control Ery
for the following genes; Hbb-εg (p = 0.002), Hbb-b (p = 0.0023), an
significantly different from each other for the following genes; Hbb-ε
Stem Csuch as transcription factors that specify specific cellular
fates. Emerging embryonic HSCs and their progeny have
been comprehensively examined via global transcriptional
profiling, which revealed key insights into hematopoietic
specification and leukemogenesis (Boisset et al., 2010;
McKinney-Freeman et al., 2012). The direct precursor to
the HSC, the HEC, has not been extensively examined, as
only an abbreviated transcriptional profile of HECs within
the murine embryo was recently elucidated using a Fluid-
igm-based approach (Swiers et al., 2013). Here, we have
utilized label-free proteomics to decipher key regulators
of embryonic hematopoiesis both in vivo and during the
directed differentiation of ESCs in vitro. This approach to
cellular profiling has the distinct advantage of identifying
only translated functional proteins present in the cell,
thus eliminating the unknown effects of post-transcrip-
tional modification that may affect mRNA translation.
Our first analysis focused on the proteomic landscape of
E10.5 and E11.5 VEC+ populations that contain ECs, HECs,
and pre-HSCs (Rybtsov et al., 2011). With this approach,
we were able to accurately identify and quantify known
regulators of the early hematopoietic programs such as
SCL/TAL1 and ALDH1A2, as well as a small cohort of pro-
teins that exhibited dramatic expression changes between
E10.5 and E11.5, providing a focused and manageable list
of candidates to interrogate as putative regulators of the
generation of type I pre-HSCs. To date, the generation of
PSC-derivedHSCs has been difficult, likely due to the unde-
fined nature of PSC differentiation culture conditions and
the lack of accurate comparison of the in vitro populations
to potential equivalent in vivo embryonic stages. Compar-
ison of D7 mESC-derived HEC populations to the E10.5
and E11.5 HEC populations revealed that our D7 HEC
population represents a developmental intermediate.
Therefore, interrogation of this dataset will help identify
the absence of key regulatory proteins, thus providing a
potential explanation for the inability of these cells to
faithfully generate HSCs in vitro.
Understanding the regulatory pathways that control the
establishment of the different hematopoietic programs and
developing methods to identify and isolate progenitors for
each are essential to accurately model hematopoiesis
in ESC and induced PSC differentiation cultures and ulti-
mately to generate HSCs in vitro. Building on our previous
observations that SOX17 is a critical regulator of definitive
hematopoiesis (Clarke et al., 2013), in this study, we pro-
ceeded to analyze the SOX17-dependent proteome inidual experiments (SEM). Control Ery-EMP:Sox17/ Ery-EMP Hbb-b
P and Ery-EMP colonies were significantly different from each other
d Stat3 (p = 0.09). The Sox17/ EryP and Ery-EMP colonies were
g (p = 0.05).
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Figure 5. Day 9 mESCs Generate Stat1+, NOTCH-Dependent, and SOX17-Dependent Definitive Erythroid Cells
(A) Schematic representation of the differentiation protocol for generating definitive hematopoietic progenitors from mESCs.
(B) Representative image of control erythroid colonies from a D9 population generated from D5.25 FLK-1+ cells after 8 days in culture.
(C) Representative flow cytometric profiles of cells in D9 populations stained with CD41.
(D) Fold change in cell numbers of D9 populations generated in the presence and absence of gSI.
(E) Erythroid potential of the D9 populations; n = 3 individual experiments (SEM). Control DMSO: control gSI p = 0.024. Control
gSI:Sox17/ gSI p = 0.0028.
(F) Real-time qPCR analysis of the erythroid colonies. n = 3 individual experiments (SEM). Control:Sox17/ Stat1 p = 0.0032, control
Stat1:Stat3 p = 0.03, control Stat1:Stat5a p = 0.03, and control Stat1:Stat5b p = 0.03.
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Figure 6. Sox17 Is Not Required for the Formation of Ery-EMP
In Vivo
(A) Erythroid potential of E8.5 YS from Sox17+/+ (n = 3), Sox17+/
(N = 6) and Sox17/ (n = 3) embryos from two dams.
(B) Real-time qPCR analysis of pooled Ery-P and Ery-EMP erythroid
colonies. n = 3 individual experiments (SEM).HECs and hematopoietic progenitors, and through this
approach, we were able to identify potential regulatory
pathways of the definitive hematopoietic program and
markers to distinguish it from the earlier primitive and
EMP programs. Specifically, we identified Stat1 as a marker
whose expression distinguishes the definitive erythroid
lineage from the primitive and EMP-derived erythroid lin-
eages. The differences observed between the EMP and
definitive programs are particularly important, as they are
difficult to distinguish by other methods. The observation
that the EMP program persists through the later definitive
stage of differentiation in the Sox17/ cultures demon-
strates that EMP progeny can persist in the PSC-derived dif-
ferentiation cultures for extended periods of time. Based on
these differential patterns of Stat1 expression, we were able
to demonstrate that SOX17 dependence is a distinguishing
factor that separates the definitive hematopoietic program
from the EMP and primitive hematopoietic programs.Stem CThe expression analyses of the mESC-derived popula-
tions showing that the D9 progenitors express Stat1 in a
SOX17-dependent fashion provide additional evidence
that we were able to specify the definitive program in the
differentiation cultures. The analyses of erythroid Stat1
expression will complement the use of T cell potential as
a method to distinguish the PSC-derived hematopoietic
programs andmonitor the emergence of the definitive line-
age in vitro. In addition to demonstrating the emergence of
the definitive lineage, our studies show that the early spec-
ification of the primitive and EMP lineages can be moni-
tored by the co-expression of Stat and globin genes. The
observation that the D3.5 FLK-1+ progenitors give rise to
both the primitive and EMP erythroid lineages that are
found in the yolk sac provides further support that the
in vitro PSC system accurately recapitulates in vivo embry-
onic hematopoiesis.
Our STAT protein expression data support the recently
published computational prediction of a differential role
for STAT signaling in primitive and definitive erythropoi-
esis (Greenfest-Allen et al., 2013). STAT signaling is central
to hematopoietic cell biology, as this pathway is activated
in response to numerous cytokines, including erythropoi-
etin (EPO) and stem cell factor (SCF/KL). The observations
that EPO activates Stat1, Stat3, Stat5a, and Stat5b in mouse
and human cell lines in culture, and that STAT1- and
STAT5-deficient fetuses display awide array of erythroid de-
fects, provide clear evidence that STAT proteins are critical
regulators of developmental erythropoiesis and erythro-
blastmaturation (Cui et al., 2004; Halupa et al., 2005; Kirito
and Komatsu, 2002; Kirito et al., 1997; Richmond et al.,
2005; Socolovsky et al., 1999, 2001). Analysis of the role
of STAT3 during erythropoiesis is hampered by the fact
that Stat3/ mice are embryonic lethal at E7.5 due to a
lack of mesoderm formation. However, small-molecule in-
hibition of STAT3 activation resulted in decreased numbers
of primitive, but not adult definitive, erythroblasts in cul-
ture, suggesting a differential role of STAT3 during distinct
stages of hematopoiesis (Greenfest-Allen et al., 2013). A
mechanism by which STAT1 may preferentially regulate
the maturation of definitive erythroid cells is through its
transcriptional target ISG15. ISG15 is strongly upregulated
during erythroid differentiation in the bone marrow (Mar-
agno et al., 2011) and was identified in our proteomics
screen as a potential SOX17 target exhibiting a parallel
expression pattern to STAT1 (Figure 2D). ISG15 can be
covalently linked to lysine residues of target proteins as a
method of post-translational modification (Zhang and
Zhang, 2011). STAT5 and globin proteins have been shown
to be ISGylated in erythroblasts, and ISG15/ erythro-
blasts are unable to terminally differentiate, thus providing
a testable hypothesis by which STAT1 regulates definitive
erythroid differentiation. Collectively, the observationell Reports j Vol. 5 j 291–304 j August 11, 2015 j ª2015 The Authors 301
that distinct developmental subsets of erythroid cells ex-
press different STAT proteins presents a previously uniden-
tified mode of regulation of embryonic erythropoiesis.
In summary, the data presented in this study demon-
strate that quantitative proteomics is an informative and
accurate method to identify global patterns of protein
expression in small numbers of cells. By applying this
approach to early hematopoietic progenitor populations,
we have gained insights into potential pathways that regu-
late embryonic hematopoietic development and uncov-
ered strategies for identifying the definitive hematopoietic
program in PSC differentiation cultures. Further compari-
son of our proteomics analysis to previously published
transcriptome datasets will provide a systems biology
view of the early stages of embryonic hematopoiesis and
allow us to obtain a better understanding of the signaling
and transcription factor networks that underlie the specifi-
cation of HSCs.EXPERIMENTAL PROCEDURES
Sample Preparation for Mass Spectrometry
50,000 cells underwent FACS. The cells were then washed in 13
PBS and flash frozen. Cell pellets were lysed in 1 M urea and
50 mM ammonium bicarbonate (pH 7.8) and heated to 50C for
20 min. Cell debris was removed by centrifugation (1,000 3 g,
2 min). Following a bicinchoninic acid assay, normalized quanti-
ties of protein were reduced with 2 mM DTT, alkylated with
15 mM iodoacetamide, and digested overnight with a 1:50 ratio
of trypsin to total protein. The resulting peptides were desalted
on Waters Sep-Pak C18 cartridges.
Nano-LC-MS/MS Measurements
Peptides were measured by nano-LC-MS/MS on a Q Exactive
(Thermo Scientific). Peptides were separated online by reverse-
phase chromatography using a heated 50C 30-cm C18 columns
(75-mm ID packed with Magic C18 AQ 5-mM/100-A beads) in a
120-min gradient (1%–45% acetonitrile with 0.1% formic acid)
separated at 250 nl/min. The Q Exactive was operated in the
data-dependent mode with the following settings: 70,000 resolu-
tion, 300–2,000 m/z full scan, Top 10, and an 1.8-m/z isolation
window.
Data Processing and Analysis
Identification and label-free quantification of peptides was done
with MaxQuant 1.3.0.5 using a 1% false discovery rate (FDR)
against the mouse Swiss-Prot/TrEMB database downloaded from
UniProt on October 11, 2013 (Cox and Mann, 2008). The data-
bases contained forward and reverse mouse sequences as well as
common contaminants. We analyzed three replicates per condi-
tion. Peptides were searched for variable modification of n-term
protein acetylation, oxidation (M), deamidation (NQ), with a
6-ppmmass error and amatch between run window of 2 min. Pro-
teins that were significantly regulated between conditions were
identified using a permutation-based t test (S1, FDR 5%) in Perseus302 Stem Cell Reports j Vol. 5 j 291–304 j August 11, 2015 j ª2015 The Aut1.4.1.3. GO terms were analyzed in G-profiler (Reimand et al.,
2011).
Real-Time qPCR
Total RNA was prepared with the RNAqueous-Micro Kit
(Ambion) and treated with RNase-free DNase (Ambion). 500 ng
to 1 mg RNA was reverse transcribed into cDNA using random
hexamers and Oligo (dT) with Superscript III Reverse Transcrip-
tase (Invitrogen). qPCR was performed on a MasterCycler EP
RealPlex (Eppendorf) using QuantiFast SYBR Green PCR Kit
(QIAGEN). Expression levels were normalized to the house-
keeping gene b-actin (Actb). The oligonucleotide sequences are
listed in Table S7.
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